Financial Data and Key Metrics Changes - For fiscal year 2025, revenue reached RMB 3.98 billion, up 43.5%, with net profit attributable to ordinary shareholders at RMB 570 million, a year-on-year growth of 64.8% [4] - Quarterly revenue in Q4 more than doubled year-on-year to RMB 1.41 billion, reflecting a growth of 105.5% [20] - Operating costs for Q4 reached RMB 680 million, a 109.2% increase year-on-year, driven by referral and service fees [21] Business Line Data and Key Metrics Changes - The insurtech segment saw revenue surge by 61.3% with an operating margin of approximately 18% [4] - Insurance-related income in Q4 surged 125% year-over-year to RMB 1.31 billion, while operating profits grew 42% year-over-year to RMB 160 million [9] - Medical consulting services generated RMB 260 million, while digital clinical trial sourcing income was RMB 118 million [20] Market Data and Key Metrics Changes - The platform has responded to 3.68 million patients since its launch, with over 4,000 patients enrolled in digital clinical trials this year [5] - The E-Find platform partnered with 224 pharmaceutical companies and enrolled a record 14,055 patients [16] Company Strategy and Development Direction - The company is accelerating its shift to become an AI-native company, aiming to embed AI as a structural competitive advantage [6][8] - The goal for 2026 is to sustain momentum with moderately higher investment in marketing and AI, targeting double-digit growth in both revenue and profit [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the execution of the AI plus insurance strategy, highlighting robust financial performance and core fundamentals [3] - The company aims to visually reconstruct its entire value chain with AI, indicating a strong commitment to innovation and efficiency [8] Other Important Information - The board approved a cash dividend of $0.03 per ADS, totaling $10.8 million, to be paid in late April to early May [5] - The company maintained a strong cash position of about RMB 3.25 billion as of the end of 2025, supporting future growth [22] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Performance and Key Metrics - For fiscal year 2025, revenue reached CNY 3.98 billion, up 43.5%, with net profit attributable to ordinary shareholders at CNY 570 million, a year-on-year growth of 64.8% [3][18] - The company achieved GAAP profitability for 16 consecutive quarters, with the insurtech segment revenue surging 61.3% and an operating margin of approximately 18% [3][18] - Operating costs for the fourth quarter reached CNY 680 million, a 109.2% year-over-year increase, driven by referral and service fees [16] Business Line Performance - Insurance-related income surged 125% year-over-year to CNY 1.31 billion, while operating profits grew 42% year-over-year to CNY 160 million [7] - Digital clinical trial revenue related to chronic disease increased by 30% this quarter compared to the previous three-quarter average [14] - Medical consulting services generated CNY 260 million, while digital clinical trial sourcing income was CNY 118 million [15] Market Data and Key Metrics - Approximately 490 million people have cumulatively donated CNY 72.3 billion to 3.68 million patients through the Waterdrop medical crowdfunding platform [11] - The company partnered with 224 pharmaceutical companies and enrolled a record 14,055 patients in its E-Find platform [12] Company Strategy and Industry Competition - The company is executing an AI plus insurance strategy, aiming to become an AI-native company by embedding AI as a structural competitive advantage [5][6] - The goal is to sustain momentum with moderately higher investment in marketing and AI, targeting double-digit growth in both revenue and profit [6] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in maintaining robust financial performance and highlighted the importance of AI integration across all service nodes [4][10] - The company aims to visually reconstruct its entire value chain, leveraging AI for operational gains and efficiency [5][6] Other Important Information - The board approved a cash dividend of $0.03 per ADS, totaling $10.8 million, to be paid in late April to early May [4] - As of year-end 2023, the company filed 72 LLM-related patent applications, including nine international ones [4] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% year-on-year increase [2] Business Line Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Operating profit for the insurtech segment reached approximately CNY 180 million, marking a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [15][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring AI applications in non-insurance areas to support growth [4] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company has maintained GAAP profitability for 15 consecutive quarters since Q1 2022 [3] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][17] - Operating profit for the insurtech business reached about CNY 180 million, a year-on-year increase of 44.3% [3][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][20] - WaterDrop C-Point AI, a low-code AI platform, was launched to enhance operational efficiency and support various business tasks [4][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company is committed to sustainable development and creating value for society through its initiatives [5] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - As of the end of September, the company held a cash position of about CNY 3.61 billion, ensuring financial support for business expansion [19] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - The company reported total revenue of CNY 975 million for Q3 2025, reflecting a year-on-year growth of 38.4% [2][16] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][18] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [6][16] - Operating profit for the insurtech segment reached approximately CNY 180 million, a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][16] Market Data and Key Metrics Changes - The medical profiling platform raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][12] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][18] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring applications of AI in non-insurance areas to support growth [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, supported by strong business performance [6] - The company emphasized the importance of AI in enhancing operational efficiency and decision-making capabilities [8][10] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, approximately 58.1 million ADS were repurchased in the open market, totaling $113 million [5] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted significant growth momentum in the insurance business, with a focus on optimizing real-time identification capabilities and enhancing product offerings [6][7] Question: How is the company addressing operational efficiency? - The company is deploying AI widely across operations, which has led to improved response times and increased productivity in various service scenarios [10][17]